Article Versions Notes

Cócera-Ortega L, Wilders R, Kamps SC, Fabrizi B, Huber I, van der Made I, van den Bout A, de Vries DK, Gepstein L, Verkerk AO, et al. shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele. International Journal of Molecular Sciences. 2022; 23(7):4053. https://doi.org/10.3390/ijms23074053

Cócera-Ortega, Lucía, Ronald Wilders, Selina C. Kamps, Benedetta Fabrizi, Irit Huber, Ingeborg van der Made, Anouk van den Bout, Dylan K. de Vries, Lior Gepstein, Arie O. Verkerk, and et al. 2022. "shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele" International Journal of Molecular Sciences 23, no. 7: 4053. https://doi.org/10.3390/ijms23074053

Cócera-Ortega, L., Wilders, R., Kamps, S. C., Fabrizi, B., Huber, I., van der Made, I., van den Bout, A., de Vries, D. K., Gepstein, L., Verkerk, A. O., Pinto, Y. M., & Tijsen, A. J. (2022). shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele. International Journal of Molecular Sciences, 23(7), 4053. https://doi.org/10.3390/ijms23074053